Targeting an enzyme in migraine

Queensland-led genetics researchers have just launched a final, phase three clinical trial for a treatment that could drastically reduce symptoms in 20% of sufferers.

The trial is headed by Professor Lyn Griffiths, the new Executive Director of QUT's Institute for Health and Biomedical Innovation.

She and her world-leading team have identified several genes implicated in migraine and are translating that genetic information into new diagnostics and treatments.

Professor Griffiths said one of those genes causes a mutation in a particular enzyme, which stops the enzyme from working properly.

"We're trialling a specific combination of vitamins that can make that enzyme work better and make the gene then function properly," she said.

http://www.thereporter.com.au/news/migraine-treatment-promises-drastically-reduce-sym/2022919/

Interesting! Although I wonder what the vitamins are. I'm assuming vitamin B2 is one of them, as I think that's the theory behind why that one works for some. Since I do find B2 helps me a bit, I'll definitely be interested in how this trial goes.

Thanks for posting.